Correspondence 0001493152-24-049668 from PALISADE BIO, INC. (PALI)
PALISADE BIO, INC.
Date: Dec. 11, 2024 · CIK: 0001357459 · Accession: 0001493152-24-049668
AI Filing Summary & Sentiment
File numbers found in text: 333-282883
Show Raw Text
CORRESP
1
filename1.htm
Ladenburg
Thalmann & Co. Inc.
640
Fifth Avenue, 4th Floor
New
York, New York 10019
December
11, 2024
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
Re:
Palisade
Bio, Inc.
Registration
Statement on Form S-1 (Registration No. 333-282883)
Withdrawal
of Concurrence in Acceleration Request
Ladies
and Gentlemen:
Reference
is made to our letter, filed as correspondence via EDGAR on December 10, 2024, in which we provided concurrence in the request for acceleration
of the effective date of the above-referenced Registration Statement for December 11, 2024, at 5:30 p.m. Eastern Time, in accordance
with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared
effective at this time.
Very
truly yours,
LADENBURG
THALMANN & CO. INC.
By:
/s/
Nicholas Stergis
Name:
Nicholas
Stergis
Title:
Managing
Director